Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
This is the protocol for a review and there is no abstract. The objectives are as follows: <br/> To determine whether alternative agents (e.g. artificial platelet substitutes, platelet-poor plasma, fibrinogen, rFVIIa, thrombopoietin mimetics) are as effective and safe as the use of platelet tr...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
John Wiley and Sons, Ltd
2014
|
| _version_ | 1826290740004651008 |
|---|---|
| author | Estcourt, L Gregg, R Stanworth, S Doree, C Trivella, M Murphy, M Tinmouth, A |
| author_facet | Estcourt, L Gregg, R Stanworth, S Doree, C Trivella, M Murphy, M Tinmouth, A |
| author_sort | Estcourt, L |
| collection | OXFORD |
| description | This is the protocol for a review and there is no abstract. The objectives are as follows: <br/> To determine whether alternative agents (e.g. artificial platelet substitutes, platelet-poor plasma, fibrinogen, rFVIIa, thrombopoietin mimetics) are as effective and safe as the use of platelet transfusions for the prevention of bleeding (prophylactic platelet transfusion) in patients with haematological disorders who are undergoing myelosuppressive chemotherapy or stem cell transplantation. Anti-fibrinolytics (lysine analogues) will not be included in this review because they have been the focus of another Cochrane review (Wardrop 2013). |
| first_indexed | 2024-03-07T02:48:48Z |
| format | Journal article |
| id | oxford-uuid:acf7b837-eeeb-40a3-906d-d2f87484c160 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:48:48Z |
| publishDate | 2014 |
| publisher | John Wiley and Sons, Ltd |
| record_format | dspace |
| spelling | oxford-uuid:acf7b837-eeeb-40a3-906d-d2f87484c1602022-03-27T03:32:23ZAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:acf7b837-eeeb-40a3-906d-d2f87484c160EnglishSymplectic Elements at OxfordJohn Wiley and Sons, Ltd2014Estcourt, LGregg, RStanworth, SDoree, CTrivella, MMurphy, MTinmouth, AThis is the protocol for a review and there is no abstract. The objectives are as follows: <br/> To determine whether alternative agents (e.g. artificial platelet substitutes, platelet-poor plasma, fibrinogen, rFVIIa, thrombopoietin mimetics) are as effective and safe as the use of platelet transfusions for the prevention of bleeding (prophylactic platelet transfusion) in patients with haematological disorders who are undergoing myelosuppressive chemotherapy or stem cell transplantation. Anti-fibrinolytics (lysine analogues) will not be included in this review because they have been the focus of another Cochrane review (Wardrop 2013). |
| spellingShingle | Estcourt, L Gregg, R Stanworth, S Doree, C Trivella, M Murphy, M Tinmouth, A Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol). |
| title | Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol). |
| title_full | Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol). |
| title_fullStr | Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol). |
| title_full_unstemmed | Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol). |
| title_short | Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol). |
| title_sort | alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation protocol |
| work_keys_str_mv | AT estcourtl alternativeagentsversusprophylacticplatelettransfusionforpreventingbleedinginpatientswithhaematologicaldisordersafterchemotherapyorstemcelltransplantationprotocol AT greggr alternativeagentsversusprophylacticplatelettransfusionforpreventingbleedinginpatientswithhaematologicaldisordersafterchemotherapyorstemcelltransplantationprotocol AT stanworths alternativeagentsversusprophylacticplatelettransfusionforpreventingbleedinginpatientswithhaematologicaldisordersafterchemotherapyorstemcelltransplantationprotocol AT doreec alternativeagentsversusprophylacticplatelettransfusionforpreventingbleedinginpatientswithhaematologicaldisordersafterchemotherapyorstemcelltransplantationprotocol AT trivellam alternativeagentsversusprophylacticplatelettransfusionforpreventingbleedinginpatientswithhaematologicaldisordersafterchemotherapyorstemcelltransplantationprotocol AT murphym alternativeagentsversusprophylacticplatelettransfusionforpreventingbleedinginpatientswithhaematologicaldisordersafterchemotherapyorstemcelltransplantationprotocol AT tinmoutha alternativeagentsversusprophylacticplatelettransfusionforpreventingbleedinginpatientswithhaematologicaldisordersafterchemotherapyorstemcelltransplantationprotocol |